222 results on '"Fischer, Melissa"'
Search Results
2. Curricular Reform in Serious Illness Communication and Palliative Care: Using Medical Students’ Voices to Guide Change
3. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
4. Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation
5. AVALIAÇÃO DE INTERPOLADORES PARA ESTIMAR CHUVA MÉDIA COM USO DA VALIDAÇÃO CRUZADA E NA RESPOSTA DO MODELO CHUVA VAZÃO
6. The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib
7. Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions
8. Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies
9. Contributors
10. Fractionated radiotherapy for pituitary adenomas
11. Maternity Leave Satisfaction Among Physicians Compared with Nonphysician Professionals.
12. A Case Report of Ependymoma in a Pregnant Client With Thoracic and Lumbopelvic Pain
13. DRIVE: Diversity, Representation, and Inclusion for Value in Education – interprofessional faculty development for a bias-free curriculum at UMass Chan Medical School
14. Figure S3 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
15. Data from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
16. Supplementary Figures and Table from A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
17. Data from A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
18. Supplemental data from BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia
19. Data from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
20. Supplementary Legends for Figures and Tables from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
21. Supplementary Figure 3 from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
22. Supplementary Figure 1 from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
23. Supplementary Figure 2 from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
24. Supplementary Table 2 from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
25. Supplementary Table 1 from MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model
26. University of Massachusetts Medical School
27. Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
28. “It feels like you have to choose one or the other”: periviability counseling focus groups
29. Perioperative Outcomes, Complications, and Efficacy of Robotic-Assisted Prolapse Repair: A Single Institution Study of 196 Patients
30. Education Research: A framework for global health curricula for neurology trainees
31. Primary HSPC-Derived Monocytes with DNMT3A p.R882H Exhibit Activated Myeloid Cell Gene Signatures
32. Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
33. Storymap: Investigating the extent and possible causes of western redcedar dieback throughout Oregon and Washington
34. Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors
35. Abstract IA-52: Improving access to research among individuals from under-represented racial and ethnic minority communities: The Strengthening Research In Diverse Enrollment (STRIDE) Study
36. A First-Year Medical School Course Integrating Development, Structure, and Function
37. PD50-12 COMPARISON OF OPERATIVE AND PERIOPERATIVE OUTCOMES BETWEEN ROBOTIC ASSISTED PROLAPSE REPAIR AND TRANSVAGINAL MESH REPAIR
38. PD21-06 PERIOPERATIVE OUTCOMES, COMPLICATIONS, AND EFFICACY OF ROBOTIC ASSISTED PROLAPSE REPAIR
39. PD20-08 THE IMPACT OF COMORBID CHRONIC PAIN SYNDROMES ON SEXUAL ACTIVITY AND DYSPAREUNIA AFTER PELVIC ORGAN PROLAPSE REPAIR
40. The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib
41. In Reply to Ramotshwana et al
42. Biotechnologically produced microbial alginate dressings show enhanced gel forming capacity compared to commercial alginate dressings of marine origin
43. BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia
44. Development of a multi-component intervention to promote participation of Black and Latinx individuals in biomedical research
45. CHATTER.
46. A Case Report of Ependymoma in a Pregnant Client With Thoracic and Lumbopelvic Pain
47. Article Commentary: Developing an Opioid Curriculum for Medical Students: A Consensus Report from a National Symposium
48. Accelerated Graduation and the Deployment of New Physicians During the COVID-19 Pandemic
49. MCL1 dependence across MDS subtypes and dual inhibition of MCL1 and BCL2 in MISTRG6 mice
50. A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.